Impact News +++ Navan (NAVN) Sued Over IPO Disclosures; Investors Face April 24 Deadline - Hagens Berman (PR Newswire) +++ NAVAN Aktie -4,27%

HEALTH CATALYST Aktie

>HEALTH CATALYST Aktienkurs

0.998 EUR (TradegateBSX)

Ask: 1.03 EUR / 5817 Stück

Bid: 0.965 EUR / 6231 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>HEALTH CATALYST Performance

1 Woche: +1,3%

1 Monat: -27,2%

3 Monate: -53,4%

6 Monate: -59,1%

1 Jahr: -76,6%

laufendes Jahr: -53,4%

>HEALTH CATALYST Aktie

Name:

HEALTH CATALYST INC.

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US42225T1079 / A2PH3J

Symbol/ Ticker:

2YP (Frankfurt) / HCAT (NASDAQ)

Kürzel:

FRA:2YP, ETR:2YP, 2YP:GR, NASDAQ:HCAT

Index:

Webseite:

https://www.healthcatalys..

Profil:

Health Catalyst Inc. is a leading provider of data and analytics technology and services to healthcare organizations throughout the United States. The company operates in two primary segments: Technology, which encompasses cloud-based subscriptions, ..
>Volltext..

Marktkapitalisierung:

75.08 Mio. EUR

Unternehmenswert:

138.79 Mio. EUR

Umsatz:

269.02 Mio. EUR

EBITDA:

2.5 Mio. EUR

Nettogewinn:

-153.88 Mio. EUR

Gewinn je Aktie:

-2.19 EUR

Schulden:

148.06 Mio. EUR

Liquide Mittel:

43.94 Mio. EUR

Operativer Cashflow:

0.63 Mio. EUR

Bargeldquote:

1.07

Umsatzwachstum:

-10.55%

Gewinnwachstum:

-125.7%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

HEALTH CATALYST

Letzte Datenerhebung:

01.04.26

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 73.59 Mio. St.

Frei handelbar: 88.19%

Leerverk. Aktien: 10.01%

Rückkaufquote: 4.02%

Mitarbeiter: 1200

Umsatz/Mitarb.: 0.22 Mio. EUR

Analysten:

Analystenrating: Neutral

Kursziel: 76.27%

Bewertung:

KGV: -

KGV lG: 9.79

KUV: 0.27

KBV: 0.33

PEG-Ratio: -

EV/EBITDA: 55.41

Rentabilität:

Bruttomarge: 33.47%

Gewinnmarge: -57.2%

Operative Marge: -15.3%

Managementeffizenz:

Gesamtkaprendite: -26.14%

Eigenkaprendite: -58.26%

>Peer Group

Gesundheit

>HEALTH CATALYST Chart & Kurs - NASDAQ

>HEALTH CATALYST News

18.03.26 - 18:57	Health Catalyst downgraded at Wells Fargo after Q4 results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

17.03.26 - 15:48	Health Catalyst (HCAT) Q4 2025 Earnings Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

13.03.26 - 16:30	Health Catalyst plummets after mixed Q4; CEO declines to rule out potential sale as part of review (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

13.03.26 - 00:45	Health Catalyst (HCAT) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
	Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....

13.03.26 - 00:45	Health Catalyst (HCAT) Lags Q4 Earnings Estimates (Zacks)
	Health Catalyst (HCAT) delivered earnings and revenue surprises of -14.26% and +1.45%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...

13.03.26 - 00:01	Health Catalyst refrains from 2026 annual guidance as new CEO launches operational overhaul and strategic review (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.03.26 - 21:18	Health Catalyst Non-GAAP EPS of $0.08 misses by $0.02, revenue of $74.8M beats by $0.81M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.03.26 - 16:30	Health Catalyst (HCAT) May Find a Bottom Soon, Here′s Why You Should Buy the Stock Now (Zacks)
	Health Catalyst (HCAT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term....

11.03.26 - 22:39	Health Catalyst Q4 2025 Earnings Preview (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

09.03.26 - 15:45	Gear Up for Health Catalyst (HCAT) Q4 Earnings: Wall Street Estimates for Key Metrics (Zacks)
	Besides Wall Street's top-and-bottom-line estimates for Health Catalyst (HCAT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025....

18.02.26 - 16:36	Health Catalyst promotes COO to CEO role; downsizes board (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

18.02.26 - 14:57	Health Catalyst Appoints Ben Albert as Chief Executive Officer (PR Newswire)
	Albert to Sharpen Focus on Improving Cost and Operational Efficiency, Clinical Quality, and Consumer Experience in Healthcare Health Catalyst Board to be Reduced to Five Directors Immediately Prior to the 2026 Annual Meeting SALT LAKE CITY, Feb. 18, 2026 /PRNewswire/ -- Health Catalyst,......

09.01.26 - 22:36	4 Analysts Have This To Say About Health Catalyst (Benzinga)
	Latest Ratings for HCAT DateFirmActionFromTo Mar 2022Piper SandlerMaintainsOverweight Mar 2022Raymond JamesMaintainsStrong Buy Mar 2022Canaccord GenuityMaintainsBuy View More Analyst Ratings for HCAT View the Latest Analyst Ratings read more...

10.12.25 - 04:01	Insiderhandel: General Counsel verkauft Aktien von Health Catalyst im Wert von 72328 USD (Insiderkauf)
	Landry, Benjamin - Vorstand - Tag der Transaktion: 2025-12-05...

10.12.25 - 04:01	Insiderhandel: Aufsichtsrat verkauft Aktien von Health Catalyst im Wert von 128349 USD (Insiderkauf)
	Larson-Green, Julie - Aufsichtsrat - Tag der Transaktion: 2025-12-04...

02.12.25 - 13:00	Matt Arens, CEO and Founder of Health Catalyst′s Largest Shareholder, First Light Asset Management, Joins Board of Directors (PR Newswire)
	SALT LAKE CITY, Dec. 2, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Matt Arens, CEO and Founder of First Light Asset......

14.11.25 - 22:18	Health Catalyst to Participate in Upcoming Investor Conferences (GlobeNewswire EN)
	SALT LAKE CITY, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences:...

11.11.25 - 05:42	KalVista, Health Catalyst, Bio-Techne Lead After-Hours Gains On Earnings Updates (AFX)
	LONDON (dpa-AFX) - Several healthcare and biotech stocks posted notable gains in Monday's after-hours trading following earnings updates and guidance revisions.KalVista Pharmaceuticals Inc. (KALV)......

11.11.25 - 04:36	Health Catalyst sees adjusted EBITDA growth to $41M in 2025 while signaling Ignite migration flexibility (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

11.11.25 - 01:45	Health Catalyst (HCAT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
	The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Don′t marry, be happy. - Hera Lind

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram